Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S. – Sarepta Therapeutics
CAMBRIDGE, Mass. –(BUSINESS WIRE)–Jul. 21, 2025– Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today…